Fluoride Content Uniformity Validation in Dental Gels Manufacturing

Fluoride Content Uniformity Validation in Dental Gels Manufacturing

Fluoride Content Uniformity Validation in the Manufacturing of Dental Gels

All equipment used in this process validation must be duly qualified and validated for its intended use and performance specifications. Equipment qualification (IQ/OQ/PQ) is assumed to be completed prior to this process validation.

Introduction

Fluoride-containing dental gels require rigorous process validation to guarantee uniform fluoride distribution and maintain therapeutic efficacy and patient safety. Content uniformity validation is essential to confirm that each batch consistently meets predefined quality attributes, particularly fluoride concentration. This ensures compliance with current Good Manufacturing Practices (cGMP) and regulatory expectations. This document provides a stepwise approach to validate fluoride content uniformity in dental gels manufacturing.

Role of Fluoride Content Uniformity Validation in cGMP and Product Consistency

Uniform fluoride content is critical to the quality and safety of dental gels. Under cGMP guidelines, consistent product content directly affects efficacy and risk profiles. Validating content uniformity demonstrates control over formulation and manufacturing processes, including mixing, blending, and filling operations. This validation mitigates risks of sub-potent or super-potent doses, which can adversely impact patient outcomes and regulatory compliance. Therefore, fluoride content uniformity validation is a pivotal quality assurance activity ensuring batch-to-batch reproducibility and minimization of process variability.

Quality Target Product Profile (QTPP) for Dental Gels

In the context of fluoride-containing dental gels, the QTPP outlines essential quality attributes required for the final product. These include:

  • Consistent fluoride concentration within established specification limits
  • Physical characteristics such as viscosity, homogeneity, and stability ensuring adequate application and patient acceptance
  • Microbial limits to comply with safety standards
  • Compatibility of ingredients ensuring product integrity and efficacy

The fluoride content uniformity directly supports the QTPP by ensuring the active pharmaceutical ingredient (API) is evenly distributed in each unit dose or tube.

Desired Attributes of Fluoride Content in Dental Gels

The primary attribute to validate during manufacturing is the fluoride ion concentration, which must meet product specifications and regulatory requirements. Desired attributes include:

  • Fluoride concentration within ±10% of label claim (dependent on pharmacopeial standards)
  • Homogeneous distribution throughout the gel matrix without localized concentrations
  • Stability of fluoride content over shelf-life and under stress conditions
  • Absence of chemical interactions or degradation affecting fluoride bioavailability

Validating these attributes requires a robust and reproducible analytical method, typically ion-selective electrode (ISE) analysis or other validated fluoride quantification techniques.

Impact of Fluoride Content Uniformity on QTPP

Fluoride content uniformity profoundly influences multiple aspects of the QTPP as follows:

  • Efficacy: Uniform fluoride dosage ensures consistent remineralization benefits and disease prevention efficacy.
  • Safety: Avoids fluoride overdose or deficiency that could potentially cause toxicity or therapeutic failure.
  • Patient Compliance: Controlled texture and fluoride levels foster patient acceptance and proper dosing.
  • Regulatory Compliance: Demonstrates process control and product quality consistency mandated by regulatory agencies.

Proper validation safeguards the product’s alignment to these critical quality metrics and therefore ensures overall product acceptability.

Critical Quality Attributes (CQAs) Related to Fluoride Content Uniformity

Identify and monitor CQAs associated with fluoride uniformity to ensure robust control of the manufacturing process. These include but are not limited to:

  • Fluoride concentration: Target concentration with strict limits verified by validated assay methods.
  • Mixing homogeneity: Distribution uniformity within the batch ensuring no stratification or settling.
  • Viscosity: Critical for maintaining fluoride suspension throughout shelf life and during application.
  • pH level: Influences fluoride stability and bioavailability.
  • Batch-to-batch variability: Minimal variation between production runs to guarantee consistent fluoride delivery.

Key Properties to Evaluate During Fluoride Content Uniformity Validation

The validation process must systematically assess key manufacturing and product attributes to confirm process robustness and uniform API distribution. Steps include:

  1. Sampling Plan: Establish a comprehensive and statistically valid sampling plan covering multiple sites and depths within batches to capture variability.
  2. Analytical Method Validation: Use and validate a reliable fluoride quantification method such as ion-selective electrode or ion chromatography for accuracy, precision, linearity, specificity, and sensitivity.
  3. Process Parameter Assessment: Evaluate critical mixing parameters (time, speed, order of addition) and filling conditions influencing uniformity.
  4. Evaluation of Blend Uniformity: Conduct intermediate sampling during blending to verify homogeneity before packaging.
  5. Validation Batches: Produce multiple consecutive batches to demonstrate consistent uniform fluoride content under routine manufacturing conditions.
  6. Data Analysis: Perform statistical analysis of content uniformity results, calculating acceptance criteria such as %RSD and comparing results against regulatory thresholds (e.g., USP uniformity of dosage units).
  7. Documentation: Record detailed validation protocols, results, deviations, and corrective actions to comply with cGMP documentation requirements.

Adhering to these steps ensures a scientifically sound approach to validating fluoride content uniformity in dental gels, preserving product quality and patient safety.

Fluoride Content Uniformity Validation in Dental Gels Manufacturing

Fluoride Content Uniformity Validation in Dental Gels Manufacturing

All equipment used in this process validation must be duly qualified and validated for its intended use and performance specifications. Equipment qualification (IQ/OQ/PQ) is assumed to be completed prior to this process validation.

Desired Attributes of Fluoride Content Uniformity in Dental Gels

Critical attributes for fluoride content uniformity validation include:

  • Precision: Accurate quantification of fluoride concentration in samples ensures uniformity across the batch.
  • Reproducibility: Analytical methods must yield consistent results under varied conditions.
  • Homogeneity: Fluoride must be evenly distributed without localized concentration fluctuations.
  • Stability: Fluoride content should remain stable throughout product shelf life to retain efficacy.

Impact of Fluoride Content Uniformity on the QTPP

Validating fluoride uniformity influences the QTPP by:

  • Ensuring dosage accuracy to deliver therapeutic fluoride levels safely.
  • Supporting physical and chemical product attributes such as gel consistency and appearance.
  • Reducing risk of adverse events related to fluoride overdose or underdose.
  • Maintaining overall product quality and regulatory compliance, reinforcing brand reliability.
See also  Emulsification Time Validation in Self-Emulsifying Drug Delivery Systems (SEDDS) Manufacturing

Critical Quality Attributes (CQAs) Related to Fluoride Uniformity

The following CQAs must be monitored during validation:

  • Fluoride Concentration Range: Defined limits based on pharmacopeial and regulatory standards.
  • Content Uniformity Acceptance Criteria: Usually expressed as % Relative Standard Deviation (%RSD) across sampled units.
  • pH Stability: Influences fluoride ion availability and product stability.
  • Viscosity: Affects the mixing efficacy and distribution of fluoride within the gel matrix.

Key Properties Affecting Fluoride Content Uniformity

Several formulation and process factors influence the fluoride content uniformity, including:

  • Mixing Parameters: Speed, time, and type of mixing equipment play critical roles in achieving homogenous dispersion.
  • Ingredient Physicochemical Properties: Solubility and particle size of fluoride compounds affect uniformity.
  • Filling Equipment Precision: Accurate volumetric or gravimetric filling prevents off-specification units.
  • Environmental Conditions: Temperature and humidity during manufacture can alter gel rheology impacting fluoride distribution.

Introduction to Fluoride Content Uniformity Validation in Dental Gels

Fluoride content uniformity validation is a critical process in dental gel manufacturing to ensure consistent therapeutic efficacy and safety. This validation confirms that fluoride is homogeneously distributed throughout the batch, meeting predefined acceptance criteria consistently. The process validation follows a structured approach involving risk assessment, design of experiments (DoE), critical process parameter (CPP) identification, control strategy development, and protocol execution.

Conduct Risk Assessment and Failure Mode and Effects Analysis (FMEA)

Begin by identifying potential risks that may impact fluoride content uniformity. Perform a Failure Mode and Effects Analysis (FMEA) to analyze possible failure points in the manufacturing process. Typical failure points to consider include:

  • Inaccurate weighing or measuring of fluoride source
  • Inadequate or uneven mixing during gel preparation
  • Variability in raw material quality
  • Contamination or equipment malfunction
  • Sampling errors during monitoring

For each failure mode, assign values for severity, occurrence, and detectability on a scale of 1 to 10:

  • Severity (S) indicates the impact on product quality or patient safety
  • Occurrence (O) estimates the likelihood of failure
  • Detectability (D) assesses the ability to detect failure before product release

Calculate the Risk Priority Number (RPN) = S × O × D. Use the RPN to prioritize which failure modes require focused mitigation efforts.

Define Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs)

Identify CPPs that directly affect fluoride uniformity. Common CPPs in dental gel manufacturing include:

  • Mixing speed and duration
  • Order and method of ingredient addition
  • Temperature during mixing
  • Viscosity control parameters
  • pH adjustment steps

The primary Critical Quality Attribute (CQA) is uniform fluoride concentration within established limits, typically ±10% of label claim. Define analytical methods for fluoride assay to evaluate CQA.

Design of Experiment (DoE) to Optimize CPPs

Use Design of Experiment (DoE) methodology to systematically evaluate the influence of CPPs on fluoride uniformity. Employ a factorial or response surface design encompassing the following steps:

  1. Select CPPs to vary (e.g., mixing speed, mixing time, temperature).
  2. Determine ranges for each parameter based on prior knowledge or preliminary studies.
  3. Define a matrix of experimental runs covering all parameter combinations.
  4. Manufacture dental gel batches according to DoE matrix.
  5. Analyze fluoride concentration uniformity for each batch.
  6. Use statistical analysis to identify significant factors and interactions.

The DoE results enable optimization of CPP ranges to ensure adequate blending and fluoride distribution.

Develop Control Strategy for Fluoride Content Uniformity

Establish a control strategy based on the optimized CPPs and risk assessment findings. This includes:

  • Routine monitoring of mixing parameters (speed, time, temperature) using validated instruments.
  • In-process sampling plan focused on multiple representative points within the batch to assess homogeneity.
  • Use of validated fluoride assay methods with appropriate sensitivity, specificity, and reproducibility.
  • Establishment of acceptance criteria for fluoride uniformity, typically using statistical process control limits.
  • Incorporation of corrective actions if analytical results fall outside acceptance limits.
  • Ongoing trending and analysis of process data to detect deviations early.

Create Validation Protocol Design

Draft a comprehensive process validation protocol that includes the following sections:

  • Objective and scope of fluoride content uniformity validation.
  • Detailed description of manufacturing process steps including preparation, mixing, and sampling.
  • Definition of CPPs, CQAs, and acceptance criteria.
  • Sampling plan specifying number of samples, sampling locations, and timing within batches.
  • Analytical methods and validation status for fluoride assay.
  • Number of process performance qualification (PPQ) batches required (typically three consecutive successful batches).
  • Data recording and evaluation methodology.
  • Predefined criteria for batch acceptance or rejection.

Process Performance Qualification (PPQ) Batch Execution

Execute PPQ batches following the approved protocol, ensuring the following:

  1. All equipment used is properly qualified (IQ/OQ/PQ completed).
  2. Raw materials meet predefined quality specifications.
  3. The manufacturing process strictly adheres to defined CPPs within established ranges.
  4. Perform sampling during and/or after mixing from predetermined locations (e.g., top, middle, bottom of batch) to verify uniform fluoride distribution.
  5. Run fluoride assays on samples with appropriate replication to assess precision.
  6. Document all process parameters and analytical results comprehensively.

Batch Evaluation and Data Analysis

After completing PPQ batch manufacturing and analysis, undertake the following evaluation steps:

  • Calculate mean fluoride content and percent relative standard deviation (RSD) across samples for each batch.
  • Compare results against acceptance criteria — typically the fluoride concentration must be within ±10% of label claim and RSD should be below predefined thresholds (usually ≤6%).
  • Review process parameter data logs to confirm adherence to CPP ranges.
  • Conduct statistical analysis to confirm consistency and uniformity of fluoride distribution.
  • Review any deviations or out-of-specification results and investigate root causes thoroughly.
  • Compile results into a formal validation report summarizing compliance with protocol requirements.

Establish Ongoing Monitoring and Control

After successful validation, implement a continued process verification plan including:

  • Periodic sampling of production batches for fluoride content uniformity assessment.
  • Real-time monitoring of CPPs during production with alert thresholds.
  • Routine calibration and maintenance of mixing and assay equipment.
  • Trend analysis of fluoride uniformity data to identify shifts or trends.
  • Process improvement initiatives if variability approaches control limits.
See also  In-vitro Release Profile Validation in Sustained Release Tablets Manufacturing

Conclusion

Fluoride content uniformity validation in dental gel manufacturing must be executed through a systematic, well-documented sequence of risk analysis, parameter optimization, control strategy development, and robust PPQ batch evaluation. Adherence to this structured process ensures product quality, patient safety, and regulatory compliance, thereby affirming that every batch delivers consistent fluoride therapeutic efficacy.

Develop Control Strategy and Establish Acceptable Ranges

Based on DoE results and risk assessment, establish a robust control strategy to maintain fluoride content uniformity throughout production. Key practical steps include:

  • Define acceptable operational ranges for each CPP within which fluoride uniformity is consistently achieved (e.g., mixing speed 300–500 rpm, mixing time 15–25 minutes).
  • Implement in-process controls such as real-time viscosity and pH measurements as indirect indicators of proper mixing.
  • Incorporate controls for raw material quality, including verified fluoride source potency and particle size distribution.
  • Specify calibration and maintenance schedules for critical equipment to prevent drift impacting uniformity.
  • Use process control charts and run-to-run data comparison during batch manufacturing.

Map Process Flow and Define Sampling & Decision Points

Create a detailed process flow diagram highlighting key steps where fluoride uniformity is vulnerable. For practical execution:

  • Identify critical sampling points, such as post-mixing, pre-filling, and post-filling stages.
  • Define sampling plans (e.g., number of samples, locations, sample size) to ensure representativeness based on batch size and mixing vessel characteristics.
  • Establish decision criteria for batch acceptance or investigation, including allowable fluoride assay variability (typically ±10% label claim).
  • Incorporate both in-process and final product testing for fluoride concentration.

Prepare Process Performance Qualification (PPQ) Protocol

Design a comprehensive PPQ protocol to empirically confirm the validated process consistently produces dental gels with uniform fluoride content. The protocol should include:

  • Specific objectives targeting fluoride uniformity and related CQAs.
  • Detailed description of process parameters to be operated within validated ranges.
  • Batch manufacturing procedures with documented adherence to defined mixing times, speeds, and ingredient addition sequences.
  • Sampling plans specifying sample size, location, and timing for fluoride assay testing.
  • Analytical methods validation for fluoride quantification, ensuring accuracy, precision, and specificity.
  • Acceptance criteria aligned with product specifications and regulatory guidance.
  • Quality assurance oversight and documentation requirements for batch records and deviations.

Execute PPQ Batches and Conduct Evaluation

Perform a minimum of three consecutive PPQ batches under normal operating conditions using the approved protocol. Practical execution steps include:

  • Verify that all CPPs remain within established control limits during batch runs.
  • Collect and analyze samples at prescribed points for fluoride concentration.
  • Document all observations, equipment status, and any deviations or out-of-specification results.
  • Evaluate fluoride assay results statistically to confirm batch-to-batch consistency and uniformity within ±10% of label claim.
  • Review process data for trends or excursions that might indicate risks to uniformity.
  • Prepare a final PPQ report summarizing results, compliance with acceptance criteria, and any corrective actions implemented.

Establish Ongoing Monitoring and Control

Post-validation, define a continuous monitoring strategy to sustain fluoride content uniformity in routine manufacturing. Recommended practices include:

  • Regular in-process testing during production runs focusing on fluoride assay and process parameters.
  • Periodic requalification of critical equipment and revalidation if process changes occur.
  • Implementation of a trending program for fluoride levels and CPPs to detect early signs of deviation.
  • Use of Statistical Process Control (SPC) tools to detect shifts or drifts in process performance.
  • Periodic review of raw material quality and supplier audits to maintain input consistency.
  • Ongoing training of personnel on critical parameters impacting fluoride uniformity.

Introduction to Fluoride Content Uniformity Validation in Dental Gels Manufacturing

Fluoride content uniformity validation is a critical component in ensuring consistent therapeutic efficacy and product safety in dental gels manufacturing. This process validation confirms that the fluoride concentration is uniformly distributed throughout the product batch and meets predefined specifications. Prior to execution, it is essential that all manufacturing equipment have completed Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) to guarantee reliable operation. This guide outlines a structured stepwise approach to validate fluoride content uniformity effectively, including verification, documentation, and routine monitoring strategies.

Define Validation Protocol and Acceptance Criteria

Begin by drafting a comprehensive Validation Protocol specifying the objective: to verify that the fluoride ion content per defined sample unit meets the acceptance criteria for uniformity. Include these key elements:

  • Detailed description of the dental gel batch size and manufacturing process
  • Sampling plan defining the number and location of samples per batch (minimum 10 per batch recommended)
  • Analytical method for fluoride quantification—validated for accuracy, precision, specificity, and linearity
  • Acceptance criteria based on pharmacopoeial standards and internal quality specifications (typically ±10% of label claim)
  • Statistical tools to be used for data evaluation, such as Relative Standard Deviation (RSD) limits (e.g., RSD ≤ 5%)

Obtain formal approval of the Validation Protocol prior to execution.

Conduct Process Performance Qualification (PPQ) Batches

Manufacture three consecutive commercial-scale batches under routine manufacturing conditions, ensuring process parameters remain within validated ranges. For each batch:

  1. Collect at least 10 samples spaced evenly throughout the bulk dental gel to represent batch heterogeneity.
  2. Analyze fluoride content in each sample using the validated analytical method.
  3. Record fluoride content results with corresponding sample locations.

Data Compilation and Tabulation of Validation Results

Create a Validation Result Table to document fluoride measurements per batch. Include:

Sample No. Batch 1 Fluoride Content (%) Batch 2 Fluoride Content (%) Batch 3 Fluoride Content (%)
1 0.95 0.96 0.94
2 1.02 1.01 1.03
3 0.99 0.98 1.00
4 1.01 1.00 1.02
5 0.97 0.95 0.96
6 0.98 1.00 0.99
7 1.00 1.02 1.01
8 0.96 0.97 0.95
9 1.03 1.04 1.02
10 0.94 0.93 0.92
See also  Drug Release Rate Validation in Solid Lipid Nanoparticles (SLNs) Manufacturing

Note: Values are illustrative and should be replaced with actual tested data.

Perform Comparative Summary and Statistical Analysis

Analyze validation batch data collectively to evaluate uniformity and batch-to-batch consistency.

  • Calculate mean fluoride content per batch.
  • Determine Relative Standard Deviation (RSD) for each batch to assess intra-batch variability.
  • Compute overall RSD combining all samples across three batches to verify process control stability.
  • Compare batch means to evaluate inter-batch consistency.

Present results within a Comparative Summary Table:

Batch No. Mean Fluoride Content (%) RSD (%) Compliance with Acceptance Criteria
Batch 1 0.985 3.5 Pass
Batch 2 0.986 3.8 Pass
Batch 3 0.974 4.0 Pass
Overall 0.982 3.77 Pass

Ensure all RSD values are below the set limit (e.g., ≤5%) and mean contents fall within ±10% of the labeled fluoride claim.

Verification and Documentation

Validate completeness and compliance via these key documents:

  • Validation Report: Summarize objectives, methodology, results, statistical analysis, deviations (if any), and final conclusion regarding process adequacy.
  • Analytical Raw Data: Maintain chromatograms or fluoride ion selective electrode readouts, calibration curves, and standard solutions data.
  • Sample Collection Records: Document sampling times, locations, batch IDs, and sample numbers.
  • Deviation and Investigation Logs: Record any process anomalies and corrective/preventive actions.

Approval and sign-off by QA, QC, and Manufacturing heads finalize the validation documentation.

Routine Monitoring and Continued Process Verification (CPV)

After process validation, implement routine monitoring to ensure ongoing fluoride content uniformity compliance:

  1. Sample and test fluoride content uniformly from each production batch at defined intervals, ideally mirroring the initial validation sampling plan.
  2. Document fluoride content results and compare against acceptance criteria.
  3. Calculate RSD for each batch to confirm consistent uniformity.
  4. Investigate and document any out-of-specification (OOS) occurrences promptly, applying corrective actions.

Maintain monitoring records to provide a continuous compliance history.

Annual Product Quality Review (APQR) and Trending

Incorporate fluoride content uniformity data into the APQR as follows:

  • Aggregate batch-wise fluoride content statistics and RSD trends over the year.
  • Perform trending analyses to identify any shifts or drifts in fluoride uniformity.
  • Evaluate process capability indices to confirm ongoing process robustness.
  • Document any corrective and preventive actions or process improvements arising from data insights.

Annexure Templates for Fluoride Content Uniformity Validation

To assist in standardizing documentation, include the following annexures within the validation package:

Annexure I: Validation Protocol Template

  • Scope and objective
  • Batch and process description
  • Sampling and analytical plan
  • Acceptance criteria
  • Roles and responsibilities
  • Approval signatures

Annexure II: Sampling Log Sheet

  • Batch number, date/time of sampling
  • Sample location within the batch
  • Sample ID and collector signature

Annexure III: Fluoride Content Analytical Worksheet

  • Sample ID
  • Method details and conditions
  • Raw analytical data and calculations
  • Tester signature and date

Annexure IV: Validation Result Tabulation Form

  • Tabulate fluoride assay results per sample and batch
  • Allow fields for mean, RSD, and comments

Annexure V: Validation Summary and Sign-Off Sheet

  • Summary of results and conclusion
  • Deviation and investigation summary
  • Final approval signatures from key departments

By following these detailed steps and documentation practices, pharmaceutical professionals can confidently validate fluoride content uniformity in dental gels, ensuring product quality and regulatory compliance.

Validation Result Tabulation and Statistical Analysis

Compile all fluoride content data from the three PPQ batches into a comprehensive table. Ensure each batch’s samples are clearly labeled and results documented in % content relative to the label claim.


Sample No. Batch 1 Fluoride Content (%) Batch 2 Fluoride Content (%) Batch 3 Fluoride Content (%)
1 [Value] [Value] [Value]
2 [Value] [Value] [Value]
3 [Value] [Value] [Value]

Calculate the mean fluoride content and Relative Standard Deviation (RSD) for each batch. Confirm all values comply with the acceptance criteria, typically RSD ≤ 5% and content within ±10% of label claim.

Comparative Summary and Compliance Assessment

Parameter Batch 1 Batch 2 Batch 3 Acceptance Criteria
Average Fluoride Content (%) [Mean Value] [Mean Value] [Mean Value] 90–110% of label claim
RSD (%) [RSD Value] [RSD Value] [RSD Value] ≤ 5%
Compliance Status [Pass/Fail] [Pass/Fail] [Pass/Fail] All batches must pass

A successful validation is achieved when all batches meet the fluoride content requirements and demonstrate consistent uniformity, indicated by low RSD and full compliance.

Continued Process Verification (CPV) and Routine Monitoring

Establish a CPV program to monitor fluoride content uniformity during routine commercial production. Key components include:

  • Sampling at predefined intervals (e.g., every production batch or every nth batch)
  • Analysis of selected samples using the validated fluoride assay
  • Recording and trending fluoride content and RSD values
  • Investigation and corrective action in case of deviation from acceptance criteria

Routine monitoring ensures continued compliance, early detection of process drift, and helps maintain consistent product quality.

Annual Product Quality Review (APQR) and Trending

Incorporate fluoride content uniformity data into the APQR to evaluate long-term process performance. Analyze trends for:

  • Batch-to-batch variability in fluoride content and RSD
  • Any excursions or out-of-specification events
  • Effectiveness of corrective and preventive actions

APQR findings support continual improvement, risk mitigation, and regulatory compliance.

Annexures

Templates are provided to standardize documentation and facilitate future validations or quality reviews.

Annexure I: Fluoride Content Uniformity Validation Protocol Template

  • Objective
  • Scope
  • Sampling plan
  • Analytical method details
  • Acceptance criteria
  • Statistical analysis plan
  • Approval signatures

Annexure II: Sampling Log Template

  • Batch number
  • Sample number
  • Collection location
  • Date/time
  • Collector’s name

Annexure III: Analytical Results Report Template

  • Sample identification
  • Fluoride content results
  • Analyst’s signature
  • Date of analysis

Annexure IV: Validation Results Tabulation Template

  • Sample numbers
  • Individual results per batch
  • Calculated means and RSD

Annexure V: CPV and Trending Log Template

  • Batch number
  • Fluoride content average and RSD
  • Investigation notes (if applicable)
  • Reviewer’s comments and signature